Established and Novel Approaches for Sarcopenia: Second Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Rehabilitation".
Deadline for manuscript submissions: 21 August 2024 | Viewed by 63
Special Issue Editor
Interests: skeletal and cardiac muscle physiology; exercise physiology; clinical exercise physiology; molecular exercise physiology; mechanotransduction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
We are pleased to announce the second edition of this Special Issue, “Established and Novel Approaches for Sarcopenia” (https://www.mdpi.com/journal/jcm/special_issues/9XI27I935X).
Sarcopenia represents the progressive age-related wasting of skeletal muscle mass accompanied by the loss of muscle strength. A decline in muscle strength and function is associated with an increased risk of adverse health outcomes, and sarcopenia patients are faced with mobility disorders, disability, a loss of independence, and reduced quality of life, while they are at a higher risk for morbidity (e.g., falls, bone fractures, and metabolic diseases, as skeletal muscle is one of the most important tissues for metabolic control) and mortality. Considering the growing elderly population and the increasing life expectancy, the prevalence of sarcopenia will escalate in the upcoming years. This provides the rationale for further characterizing the molecular mechanisms and abnormalities of sarcopenia, including abnormal energy metabolism, mitochondrial dysfunction, and myofiber type transition, as the basis for revealing and effectively treating its risk factors, thus developing efficient preventive and therapeutic strategies. Herein, we set up a Special Issue to incorporate papers focusing on established and novel approaches for sarcopenia, including, but not limited to, nutrition supplementation, pharmacological approaches, and physical exercise as interventions for sarcopenia. The Special Issue aims to present established, advanced, and novel insights for preventing or treating sarcopenia to decrease its comorbidities, and hence improve quality of life, increase life expectancy, and limit healthcare costs for these patients.
Dr. Anastassios Philippou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcopenia
- skeletal muscle wasting
- muscle atrophy
- myopathy
- muscle protein catabolism
- abnormal energy metabolism
- mitochondrial dysfunction
- myofiber type transition
- morbidity
- treatment strategies
